Gubra A/S listed in Nasdaq Copenhagen

Today, the Danish company Gubra A/S has it’s first listing day on Nasdaq Copenhagen. The company is specialised in pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases.

Gorrissen Federspiel has assisted Skandinaviska Enskilda Banken, Danmark, filial af Skandinaviska Enskilda Banken AB (publ), Sverige  and ABG Sundal Collier Denmark, filial af ABG Sundal Collier ASA, Norge on the transaction.

From Gorrissen Federspiel the team consisted of Chantal Pernille Patel Simonsen, Niels Bang, Emily Nordin, Nicolas Daniel Guichard and Nicolai Pelé Penzien Mamsen.